About Us
YOUR Cancer is not just about your cancer: it’s about making it OUR cancer.
Launched by AstraZeneca in 2018, YOUR Cancer is a platform reaching national and community difference makers focused on catalyzing the oncology community to redefine cancer care. As we continue to identify real solutions to ensure that patient-centric, coordinated care is available to everyone who needs it, we come closer to achieving our bold ambition of one day eliminating cancer as a cause of death.
YOUR Cancer seeks to build a future where we can realize the potential of a cure for all people with cancer. And where all have equitable access to the latest screens, genomic tests, and targeted therapies. We are rallying organizations and change-makers in the cancer community, harnessing the power of diverse perspectives to achieve our objectives at the intersection of four key pillars: precision medicine, early intervention, access and health equity, and equality.
Precision Medicine
Delivering the latest advancements in targeted therapies to all people who stand to benefit.
Health Equity
Ensuring that medically underserved communities are benefitting from the latest screens and treatments.
Early Intervention
Encouraging timely wellness visits for earlier diagnosis and treatment.
Access
Finding new ways to expand timely and quality care to all people in need.
About the Program Sponsor – AstraZeneca
AstraZeneca’s goal is to serve as a convener and enabler of those in the cancer community who are helping us to achieve the goal of eliminating cancer as a cause of death.
We have a deep-rooted heritage in oncology with current medicines in lung, ovarian, breast and blood cancers and a commitment to following the science to bring new treatments to earlier stages of disease and new tumor types. Our goal is to ensure that each individual is able to get personalized treatment – the right medicine, for the right person – and to transform lives through innovative medicines.
By harnessing the power of four scientific platforms – Immuno-Oncology, Tumor Drivers and Resistance, DDR and Antibody Drug Conjugates – and by championing the development of personalized combinations, AstraZeneca has the vision to redefine cancer treatment and one day eliminate cancer as a cause of death.
For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.